Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Pariente

Showing results (141-150 of 220) with videos related to

Pageof 22
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2011
Economic impact of nonpersistence with antidepressant treatment in the adult population of Quebec: a comparative cost-effectiveness approachSarah-Gabrielle Béland, Marie Tournier, Guillaume Galbaud du Fort, et al.
Expert Opinion on Drug Safety|April 5, 2014
Cardiovascular events associated with the long-term use of NSAIDs: a review of randomized controlled trials and observational studiesFrancesco Salvo, Stefania Antoniazzi, Mai Duong, et al.
Drug Safety|December 31, 2015
A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting DatabasesMickael Arnaud, Francesco Salvo, Ismaïl Ahmed, et al.
British Journal of Clinical Pharmacology|June 18, 2019
Ticagrelor and central sleep apnoea: Impact of withdrawal and reintroductionVincent Puel, Hélène Théophile, Isabelle Godard, et al.
European Journal of Clinical Pharmacology|January 8, 2018
Antipsychotics use: 2006-2013 trends in prevalence and incidence and characterization of usersFrançois Montastruc, Anne Bénard-Laribière, Pernelle Noize, et al.
JAMA Network Open|December 4, 2025
Angiogenesis Inhibitors and Arterial Dissection or Aneurysm in Patients With Metastatic Colorectal CancerAllison Singier, Ana Jarne Munoz, Sandy Maumus-Robert, et al.
BMJ (Clinical Research Ed.)|September 12, 2014
Benzodiazepine use and risk of Alzheimer's disease: case-control studySophie Billioti de Gage, Yola Moride, Thierry Ducruet, et al.
Journal of Clinical Epidemiology|July 24, 2012
Validity of chronic drug exposure presumed from repeated patient interviews varied according to drug classPernelle Noize, Fabienne Bazin, Antoine Pariente, et al.
Acta Diabetologica|June 17, 2019
Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug-drug interactions through the FDA adverse event reporting systemIppazio Cosimo Antonazzo, Elisabetta Poluzzi, Emanuele Forcesi, et al.
Health Informatics Journal|October 1, 2019
Pharmacology and social media: Potentials and biases of web forums for drug mention analysis-case study of FranceBissan Audeh, François-Elie Calvier, Florelle Bellet, et al.
Pageof 22

Showing results (141-150 of 220) with videos related to

Sort By:
Pageof 22
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2011
Economic impact of nonpersistence with antidepressant treatment in the adult population of Quebec: a comparative cost-effectiveness approachSarah-Gabrielle Béland, Marie Tournier, Guillaume Galbaud du Fort, et al.
Expert Opinion on Drug Safety|April 5, 2014
Cardiovascular events associated with the long-term use of NSAIDs: a review of randomized controlled trials and observational studiesFrancesco Salvo, Stefania Antoniazzi, Mai Duong, et al.
Drug Safety|December 31, 2015
A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting DatabasesMickael Arnaud, Francesco Salvo, Ismaïl Ahmed, et al.
British Journal of Clinical Pharmacology|June 18, 2019
Ticagrelor and central sleep apnoea: Impact of withdrawal and reintroductionVincent Puel, Hélène Théophile, Isabelle Godard, et al.
European Journal of Clinical Pharmacology|January 8, 2018
Antipsychotics use: 2006-2013 trends in prevalence and incidence and characterization of usersFrançois Montastruc, Anne Bénard-Laribière, Pernelle Noize, et al.
JAMA Network Open|December 4, 2025
Angiogenesis Inhibitors and Arterial Dissection or Aneurysm in Patients With Metastatic Colorectal CancerAllison Singier, Ana Jarne Munoz, Sandy Maumus-Robert, et al.
BMJ (Clinical Research Ed.)|September 12, 2014
Benzodiazepine use and risk of Alzheimer's disease: case-control studySophie Billioti de Gage, Yola Moride, Thierry Ducruet, et al.
Journal of Clinical Epidemiology|July 24, 2012
Validity of chronic drug exposure presumed from repeated patient interviews varied according to drug classPernelle Noize, Fabienne Bazin, Antoine Pariente, et al.
Acta Diabetologica|June 17, 2019
Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug-drug interactions through the FDA adverse event reporting systemIppazio Cosimo Antonazzo, Elisabetta Poluzzi, Emanuele Forcesi, et al.
Health Informatics Journal|October 1, 2019
Pharmacology and social media: Potentials and biases of web forums for drug mention analysis-case study of FranceBissan Audeh, François-Elie Calvier, Florelle Bellet, et al.
Pageof 22